NHVMAS News

New HIV Prevention Technologies – HIV Vaccines

The promise of an effective HIV vaccine has always been just over the horizon, but more than 20 years after the identification of HIV, vaccines remain far from implementation. The two large HIV vaccine studies till date have shown no protective effect.The latest is...

read more

Prevention of Mother to Child Transmission (PMTCT)

Mother to child transmission remains a major means of HIV transmission. HIv can be transmitted from the mother to the child through 3 routes: 1. During pregnancy when the mother goes through trauma that may cause a tear in the placenta and allow direct contact between...

read more

Interpreting the results of HIV prevention trials (2)

Clinical Trial Results Are Valuable. This is because: 1. They can tell us which products are not studying anymore 2. They can point to the kinds of changes that could be made to improve other clinical trial design 3. They may yield beneficial information about...

read more

Could vaginal microbicides protect men more so than women?

In the July 15, 2008 issue of the Proceedings of the National Academy of Sciences (http://www.pnas.org), Dr. Sally Blower and her colleagues report that mathematical models of real-world use of ARV-based vaginal microbicides predict that men may actually derive...

read more

HSV-2 treatment does not reduce the risk of HIV infection

As we first reported in the April 18, 2008 issue of GC News, although number of studies have shown that herpes simplex virus type 2 (HSV-2) infection is associated with an increased likelihood of acquiring HIV, treating people who have HSV-2 doesn't reduce their risk...

read more

Identified risk factor for HIV infection in women

In a set of recently published articles, Depovera, a hormonal contracepptive, has been found to increase the risk for HIV infection in women in real life in women in Kenya, Lesotho, Malawi an Zimbabwe. The study noted that injectable contraception was associated with...

read more

Like Us On Facebook